<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T01:02:14Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6561209" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6561209</identifier>
        <datestamp>2019-06-17</datestamp>
        <setSpec>pnas</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
              <journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
              <journal-id journal-id-type="hwp">pnas</journal-id>
              <journal-id journal-id-type="pmc">pnas</journal-id>
              <journal-id journal-id-type="publisher-id">PNAS</journal-id>
              <journal-title-group>
                <journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0027-8424</issn>
              <issn pub-type="epub">1091-6490</issn>
              <publisher>
                <publisher-name>National Academy of Sciences</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6561209</article-id>
              <article-id pub-id-type="pmcid">PMC6561209</article-id>
              <article-id pub-id-type="pmc-uid">6561209</article-id>
              <article-id pub-id-type="pmid">31085656</article-id>
              <article-id pub-id-type="pmid">31085656</article-id>
              <article-id pub-id-type="publisher-id">201818433</article-id>
              <article-id pub-id-type="doi">10.1073/pnas.1818433116</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Biological Sciences</subject>
                  <subj-group>
                    <subject>Population Biology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Applied Mathematics</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Decreasing measles burden by optimizing campaign timing</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thakkar</surname>
                    <given-names>Niket</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>a</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor1">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gilani</surname>
                    <given-names>Syed Saqlain Ahmad</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hasan</surname>
                    <given-names>Quamrul</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff3">
                    <sup>c</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9148-8448</contrib-id>
                  <name>
                    <surname>McCarthy</surname>
                    <given-names>Kevin A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">
                    <sup>a</sup>
                  </xref>
                </contrib>
                <aff id="aff1"><sup>a</sup>Institute for Disease Modeling, Bellevue, <addr-line>WA</addr-line> 98005;</aff>
                <aff id="aff2"><sup>b</sup>Ministry of National Health Services, Regulations, and Coordination, Islamabad, <country>Pakistan</country>;</aff>
                <aff id="aff3"><sup>c</sup><institution>National Institute of Health</institution>, Islamabad, <country>Pakistan</country></aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>nthakkar@idmod.org</email>.</corresp>
                <fn fn-type="edited-by">
                  <p>Edited by Burton H. Singer, University of Florida, Gainesville, FL, and approved April 19, 2019 (received for review October 25, 2018)</p>
                </fn>
                <fn fn-type="con">
                  <p>Author contributions: N.T., S.S.A.G., Q.H., and K.A.M. designed research; N.T. performed research; N.T. analyzed data; N.T., Q.H., and K.A.M. wrote the paper; and S.S.A.G. and Q.H. collected data.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="ppub">
                <day>28</day>
                <month>5</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>13</day>
                <month>5</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>13</day>
                <month>5</month>
                <year>2019</year>
              </pub-date>
              <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
              <volume>116</volume>
              <issue>22</issue>
              <fpage>11069</fpage>
              <lpage>11073</lpage>
              <permissions>
                <copyright-statement>Copyright © 2019 the Author(s). Published by PNAS.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
                  <ali:license_ref specific-use="vor">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This open access article is distributed under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND)</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="pnas.201818433.pdf"/>
              <abstract abstract-type="executive-summary">
                <title>Significance</title>
                <p>Measles vaccine is a highly effective healthcare intervention, but getting vaccine to those in need remains a major problem. Complicating the issue, high-burden countries typically have low-quality infrastructure, severely limiting the number of infections detected and therefore limiting our understanding of local epidemiology. Here we show that statistical disease models can be fitted to sparse case data from Pakistan using a fast linear regression approach. This method yields estimates of the effects of past interventions, the seasonal likelihood of measles transmission, and the magnitude of future outbreaks under different intervention policies. We use these models to understand in general when and where vaccine should be distributed, and these results were used to inform Pakistan’s 2018 vaccination campaign planning.</p>
              </abstract>
              <abstract>
                <p>Measles remains a major contributor to preventable child mortality, and bridging gaps in measles immunity is a fundamental challenge to global health. In high-burden settings, mass vaccination campaigns are conducted to increase access to vaccine and address this issue. Ensuring that campaigns are optimally effective is a crucial step toward measles elimination; however, the relationship between campaign impact and disease dynamics is poorly understood. Here, we study measles in Pakistan, and we demonstrate that campaign timing can be tuned to optimally interact with local transmission seasonality and recent incidence history. We develop a mechanistic modeling approach to optimize timing in general high-burden settings, and we find that in Pakistan, hundreds of thousands of infections can be averted with no change in campaign cost.</p>
              </abstract>
              <kwd-group>
                <kwd>measles elimination</kwd>
                <kwd>time series</kwd>
                <kwd>mathematical model</kwd>
                <kwd>vaccine</kwd>
              </kwd-group>
              <counts>
                <page-count count="5"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p content-type="flushleft">Measles is a significant source of global disease burden and child mortality, estimated to have caused 7 million infections and 90,000 deaths in 2016 (<xref rid="r1" ref-type="bibr">1</xref>). Although an effective, safe, and cost-efficient measles vaccine has existed since the 1960s, vaccination in high-burden settings remains a challenge due largely to poor healthcare infrastructure and access (<xref rid="r1" ref-type="bibr">1</xref><xref rid="r2" ref-type="bibr"/>–<xref rid="r3" ref-type="bibr">3</xref>). As a result, measles vaccine dissemination is a pressing global health and social justice issue.</p>
            <p>While routine immunization (RI) at 9 mo and 15 mo of age is the World Health Organization (WHO) recommended vaccination schedule (<xref rid="r2" ref-type="bibr">2</xref>), high-burden settings rely heavily on mass vaccination campaigns, termed supplemental immunization activities (SIAs), to provide measles vaccine more broadly (<xref rid="r3" ref-type="bibr">3</xref>). In these campaigns, health workers advertise and run fixed postvaccination sites to target all children in a specified age range with the aim to vaccinate susceptible children missed by RI (<xref rid="r3" ref-type="bibr">3</xref>). SIAs are logistically complicated and implementing them successfully requires a combination of operational excellence, planning, and knowledge of region-specific needs. While understanding and optimizing SIA implementation is therefore a difficult general problem, it is a critical contributor to measles burden control and an important step toward global measles elimination.</p>
            <p>In this report we analyze measles in Pakistan, a high-burden setting (<xref rid="r4" ref-type="bibr">4</xref>), and show that SIA impact is strongly dependent on timing. We present a general time-series susceptible–infected–recovered (TSIR) model (<xref rid="r5" ref-type="bibr">5</xref>) which explicitly accounts for SIAs in the process of inferring the underlying susceptible population, transmission seasonality, and future infections. Fitting this model to laboratory-confirmed measles cases from 2012 to 2017, we show that Pakistan has significant annual measles transmission seasonality with a high-transmission season beginning in October and continuing through the following April. This seasonality has implications for SIA timing, and using the model to extrapolate from 2018 to 2021, we show that an SIA conducted in November prevents on average <inline-formula><mml:math id="i1"><mml:mo>∼</mml:mo><mml:mn>400,000</mml:mn></mml:math></inline-formula> more infections than an equivalent campaign run in January. Finally, by extending the model to the province level, we show that optimal SIA timing is spatially heterogeneous, and we discuss implications of this result for future SIA planning in Pakistan and elsewhere.</p>
            <sec id="s1">
              <title>Measles Transmission Seasonality in Pakistan</title>
              <p content-type="flushleft">Measles is a highly virulent disease, and laboratory-confirmed measles cases in Pakistan have more than doubled from 2016 to 2017 (<xref rid="r4" ref-type="bibr">4</xref>). Pakistan’s most recent Demographic and Health Survey (DHS) (2012–2013) estimates measles vaccination coverage in 1- to 2-y olds at <inline-formula><mml:math id="i2"><mml:mn>61.4</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> nationwide, with significant subnational heterogeneity (<inline-formula><mml:math id="i3"><mml:mn>26.4</mml:mn></mml:math></inline-formula>–<inline-formula><mml:math id="i4"><mml:mn>85.2</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula>) (<xref rid="r6" ref-type="bibr">6</xref>). Given this relatively low RI coverage, informed and effective SIAs are needed to slow and potentially interrupt measles transmission.</p>
              <p>Mechanistic modeling allows us to understand measles seasonality while estimating underlying susceptible populations and forecasting policy outcomes. TSIR models of measles are well studied (<xref rid="r7" ref-type="bibr">7</xref><xref rid="r8" ref-type="bibr"/><xref rid="r9" ref-type="bibr"/>–<xref rid="r10" ref-type="bibr">10</xref>) and have been used to understand measles transmission in a variety of settings (<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref>). While modern TSIR methods typically use Markov chain Monte Carlo (<xref rid="r13" ref-type="bibr">13</xref>) or related algorithms (<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>) to calibrate to incidence data, we forgo this complexity and instead extend the more computationally robust linear-regression approach (<xref rid="r5" ref-type="bibr">5</xref>) to the high-burden context by incorporating past interventions.</p>
              <p>Considering time in semimonthly increments corresponding to a measles infection’s typical duration (<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r16" ref-type="bibr">16</xref>), we model <inline-formula><mml:math id="i5"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, the susceptible population at time <inline-formula><mml:math id="i6"><mml:mi>t</mml:mi></mml:math></inline-formula>, and <inline-formula><mml:math id="i7"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, the corresponding infection prevalence at time <inline-formula><mml:math id="i8"><mml:mi>t</mml:mi></mml:math></inline-formula>, as a discrete, stochastic dynamical system,<disp-formula id="eq1"><mml:math id="me1"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math><label>[1]</label></disp-formula><disp-formula id="eq2"><mml:math id="me2"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>α</mml:mi></mml:mrow></mml:msubsup><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math><label>[2]</label></disp-formula><disp-formula id="eq3"><mml:math id="me3"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>Binom</mml:mtext><mml:mfenced open="{" close="}"><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><label>[3]</label></disp-formula>Here, <inline-formula><mml:math id="i9"><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is an assumed known estimate of births missed by RI at time <inline-formula><mml:math id="i10"><mml:mi>t</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="i11"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the fraction of the susceptible population reached by any SIA at time <inline-formula><mml:math id="i12"><mml:mi>t</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="i13"><mml:mi>α</mml:mi></mml:math></inline-formula> models inhomogeneous population mixing (<xref rid="r5" ref-type="bibr">5</xref>), and <inline-formula><mml:math id="i14"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the average number of infectious contacts per person at time <inline-formula><mml:math id="i15"><mml:mi>t</mml:mi></mml:math></inline-formula> which we assume has an annual periodicity. Transmission uncertainty is accounted for by <inline-formula><mml:math id="i16"><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, a zero-mean, log-normal random process, and laboratory-confirmed cases, <inline-formula><mml:math id="i17"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, are assumed to be drawn from a binomial distribution where <inline-formula><mml:math id="i18"><mml:mi>p</mml:mi></mml:math></inline-formula> is the laboratory-reporting rate, an unknown probability for cases to be selected for laboratory study. In <xref ref-type="disp-formula" rid="eq1">Eq. <bold>1</bold></xref> children missed by RI, <inline-formula><mml:math id="i19"><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, contribute to <inline-formula><mml:math id="i20"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> while infections and SIAs serve to decrease <inline-formula><mml:math id="i21"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Simultaneously, <xref ref-type="disp-formula" rid="eq2">Eq. <bold>2</bold></xref> models new infections occurring at rate <inline-formula><mml:math id="i22"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> as infectious and susceptible populations interact.</p>
              <p>Since measles SIAs happen relatively infrequently, Pakistan’s campaign history can be used to reduce <inline-formula><mml:math id="i23"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> to the estimation of a single parameter. Subnational vaccination campaigns have been conducted six times in Pakistan since 2012 with wide variation in target population (<xref rid="r17" ref-type="bibr">17</xref>). Here we assume that nonzero <inline-formula><mml:math id="i24"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mi>μ</mml:mi></mml:math></inline-formula> where <inline-formula><mml:math id="i25"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the known target population fraction and <inline-formula><mml:math id="i26"><mml:mi>μ</mml:mi></mml:math></inline-formula> is an unknown SIA efficacy parameter common to all campaigns from 2012 to 2017.</p>
              <p>Given the observed <inline-formula><mml:math id="i27"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> series and corresponding <inline-formula><mml:math id="i28"><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> [via RI coverage estimates (<xref rid="r6" ref-type="bibr">6</xref>) and birth-rate estimates (<xref rid="r18" ref-type="bibr">18</xref><xref rid="r19" ref-type="bibr"/>–<xref rid="r20" ref-type="bibr">20</xref>)] (<xref ref-type="sec" rid="s4"><italic>Methods</italic></xref>), the model can be fitted to data in a two-step linear-regression process described in <xref ref-type="sec" rid="s4"><italic>Methods</italic></xref> and <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 2</ext-link>. Model calibration yields estimates of <inline-formula><mml:math id="i29"><mml:mi>α</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="i30"><mml:mi>μ</mml:mi></mml:math></inline-formula>, <inline-formula><mml:math id="i31"><mml:mi>p</mml:mi></mml:math></inline-formula>, and <inline-formula><mml:math id="i32"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> with uncertainty due both to underreporting and to transmission stochasticity.</p>
              <p>Fitting the model to national-level reports yields <inline-formula><mml:math id="i33"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>0.23</mml:mn><mml:mo>±</mml:mo><mml:mn>0.04</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula>, indicating, in qualitative agreement with similar estimates from high-burden settings (<xref rid="r21" ref-type="bibr">21</xref>), that a single laboratory-confirmed case corresponds on average to <inline-formula><mml:math id="i34"><mml:mo>∼</mml:mo><mml:mn>400</mml:mn></mml:math></inline-formula> infections in the population. Simultaneously, we find <inline-formula><mml:math id="i35"><mml:mi>α</mml:mi><mml:mo>=</mml:mo><mml:mn>0.93</mml:mn><mml:mo>±</mml:mo><mml:mn>0.03</mml:mn></mml:math></inline-formula>, indicating that inhomogeneous population mixing is a small but statistically significant effect. Past SIA efficacy <inline-formula><mml:math id="i36"><mml:mi>μ</mml:mi></mml:math></inline-formula> is estimated to be <inline-formula><mml:math id="i37"><mml:mn>40</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula>, which shows that campaign efforts have had a significant effect on measles susceptibility in Pakistan.</p>
              <p>In <xref ref-type="fig" rid="fig01">Fig. 1</xref>, national-level reports from 2012 to 2017 are aggregated by month (gray bars), showing that the majority of measles cases occur in the first half of the year. The inferred <inline-formula><mml:math id="i38"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> consistent with this case distribution is averaged by month and overlaid in red (SD cloud), showing that low transmission occurs between May and October (blue), Pakistan’s hot, summer rainy season. This correlation between measles transmission and rainfall or temperature agrees with findings from research in other settings (<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r22" ref-type="bibr">22</xref>) and suggests that transmission fluctuates in part due to weather-related variation in contact rates.</p>
              <fig id="fig01" fig-type="featured" orientation="portrait" position="float">
                <label>Fig. 1.</label>
                <caption>
                  <p>Measles transmission seasonality in Pakistan. Laboratory-confirmed cases from 2012 to 2017 aggregated by month are plotted as gray bars. The corresponding inferred force of infection (red trace, SD cloud) shows that transmission varies by as much as <inline-formula><mml:math id="i39"><mml:mn>50</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> throughout the year, with a low-transmission season (blue line) from May through September, Pakistan’s summer rainy season.</p>
                </caption>
                <graphic id="gra1" xlink:href="pnas.1818433116fig01"/>
              </fig>
              <p>Seasonal population migration and associated changes in population density have also been correlated with measles incidence in urban settings (<xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r24" ref-type="bibr">24</xref>). We test this hypothesis in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 2</ext-link> by computing annual variation in nighttime light satellite imagery brightness (<xref rid="r25" ref-type="bibr">25</xref>) near Pakistan’s largest cities, Karachi and Lahore. As shown in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6</ext-link>, our inferred <inline-formula><mml:math id="i40"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is highly correlated (Pearson correlation 0.725) with this measure of Pakistan’s urban population density, suggesting that annual rural-to-urban migration is also a driver of Pakistan’s transmission seasonality.</p>
              <p>Interestingly, the increase in transmission precedes the rise in cases by 2–3 mo. This phase difference is in quantitative agreement with seasonality studies of measles in the preelimination United States (<xref rid="r26" ref-type="bibr">26</xref>), suggesting that although a measles infection’s duration is only 2–3 wk, high transmission is required for a considerable time before enough infections have occurred to spark an outbreak. Operationally speaking, this is a valuable insight since lows in the aggregated case count alone might incorrectly suggest that Pakistan’s low measles transmission season ranges from July to November.</p>
              <p>Model seasonality and corresponding extrapolation ability are tested against laboratory reporting-rate scaled cases (black dots) in <xref ref-type="fig" rid="fig02">Fig. 2</xref>. In red, predicted <inline-formula><mml:math id="i41"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> given <inline-formula><mml:math id="i42"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> shows that the model is capable of reliable semimonthly prediction (<inline-formula><mml:math id="i43"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>≈</mml:mo><mml:mn>0.89</mml:mn></mml:math></inline-formula>) with relatively low uncertainty (red cloud, <inline-formula><mml:math id="i44"><mml:mn>95</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> CI). A more substantial test of the model is shown in black, where <inline-formula><mml:math id="i45"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is predicted for a full 6 y starting with <inline-formula><mml:math id="i46"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula> in January 2012. This long-term model prediction has larger uncertainty (gray cloud, <inline-formula><mml:math id="i47"><mml:mn>95</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> CI) as expected and captures the major outbreaks in 2013, 2016, and 2017 (<inline-formula><mml:math id="i48"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>≈</mml:mo><mml:mn>0.35</mml:mn></mml:math></inline-formula>), demonstrating that the inferred seasonality is consistent with the observed dynamics. The corresponding inferred <inline-formula><mml:math id="i49"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is plotted in blue, showing stark decreases in susceptible population following SIAs (gray dashed lines) with heterogeneity between SIAs due largely to differences in target population. Finally, in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 3</ext-link>, we demonstrate that when data past March 2017 are withheld from model fitting, out-of-sample model extrapolation successfully predicts the severity and timing of the 2017 outbreak.</p>
              <fig id="fig02" fig-type="figure" orientation="portrait" position="float">
                <label>Fig. 2.</label>
                <caption>
                  <p>Testing model performance. (<italic>Lower</italic>) Semimonthly (red) and 6-y (black) model extrapolations are compared with laboratory reporting-rate scaled cases demonstrating that the model predicts outbreak timing and magnitude. (<italic>Upper</italic>) The underlying susceptible population (blue) corresponding to the long-term projection highlights the potentially strong effect of SIAs (gray dashed lines). For all traces, shaded regions indicate <inline-formula><mml:math id="i50"><mml:mn>95</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> CIs.</p>
                </caption>
                <graphic id="gra2" xlink:href="pnas.1818433116fig02"/>
              </fig>
            </sec>
            <sec id="s2">
              <title>Optimal SIA Timing</title>
              <p content-type="flushleft">An effective vaccination campaign immunizes susceptible individuals to stifle measles transmission before it occurs. SIAs accomplish this in the model by decreasing both <inline-formula><mml:math id="i51"><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in <xref ref-type="disp-formula" rid="eq1">Eq. <bold>1</bold></xref> and the resulting <inline-formula><mml:math id="i52"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> in <xref ref-type="disp-formula" rid="eq2">Eq. <bold>2</bold></xref>. Intuitively, based on the seasonality of <xref ref-type="fig" rid="fig01">Fig. 1</xref>, we expect that SIAs in Pakistan will have greatest impact in October or November since the susceptible population built up over the summer low-transmission season can be immunized before high transmission begins. Using the model, we demonstrate that this intuition is qualitatively correct, but a given population’s recent measles history also affects optimal SIA timing.</p>
              <p>Hypothetical SIA policies can be quantitatively compared by calculating projected infections. Here, we focus on SIAs run in 2018 over the course of a full month with half the population targeted in each semimonthly model period, and we compute the sample distribution of total infections from 10,000 model runs starting with the data at the end of 2017 and forecasting for 3 y. The 2018–2021 forecasting period was selected since, in practice, multiple SIAs will be run in <inline-formula><mml:math id="i53"><mml:mo>&gt;</mml:mo><mml:mn>3</mml:mn></mml:math></inline-formula>-y periods, and we are interested in comparing effects of single SIAs for simplicity. All hypothetical campaigns have efficacy equal to the inferred 2012–2017 efficacy, <inline-formula><mml:math id="i54"><mml:mi>μ</mml:mi><mml:mo>=</mml:mo><mml:mn>40</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula>, to isolate the effects of SIA timing.</p>
              <p>Expected infections under hypothetical 2018 SIA policies are plotted in black in <xref ref-type="fig" rid="fig03">Fig. 3<italic>A</italic></xref>. As anticipated based on the seasonality, a November SIA has greatest impact, with <inline-formula><mml:math id="i55"><mml:mo>∼</mml:mo><mml:mn>440,000</mml:mn></mml:math></inline-formula> fewer infections on average than an otherwise equivalent campaign run in January. Moreover, if the extra 10 mo to prepare leads to increases in SIA efficacy, we find that November rapidly becomes even more strongly favored (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, Fig. S6</ext-link>). Throughout the low-transmission season (shaded blue region), campaigns become more and more effective. This is as we would expect since susceptible population buildup results in a wider-reaching campaign with greater herd-immunity effects (<ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 5</ext-link>).</p>
              <fig id="fig03" fig-type="figure" orientation="portrait" position="float">
                <label>Fig. 3.</label>
                <caption>
                  <p>Optimizing SIA timing in Pakistan. (<italic>A</italic>) Comparing total expected infections in 2018–2021 (black, SE shading) under different SIA policies shows that November minimizes measles burden by taking advantage of susceptible buildup over the low-transmission season (blue region). As a result however, delays into the 2018–2019 high-transmission season (red, SE shading) are costly. (<italic>B</italic>) Model projections for pre– (April) and post–low-transmission season (November) SIAs (black dashed lines) demonstrate the tradeoff between 2018 and 2020 outbreak control. As a result, 2017 measles burden also plays a significant role in timing optimization. (<italic>C</italic>) Extending the model to the province level allows us to compare April and November SIA timing subnationally. Preference for April is mapped in red while preference for November is mapped in purple; gray provinces [Federally Administered Tribal Areas and Azad Kashmir, representing less than <inline-formula><mml:math id="i56"><mml:mn>5</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> of Pakistan’s total population (<xref rid="r20" ref-type="bibr">20</xref>)] are inaccessible to health workers while white areas indicate disputed territory. Heterogeneity in the 2017 laboratory-confirmed measles cases per 100,000 (indicated) is reflected in the timing optimization.</p>
                </caption>
                <graphic id="gra3" xlink:href="pnas.1818433116fig03"/>
              </fig>
              <p>As a direct consequence of this, however, delays past November rapidly incur large costs since the 2018–2019 high-transmission season depletes the susceptible population and mitigates the effect of an SIA. This is demonstrated in <xref ref-type="fig" rid="fig03">Fig. 3<italic>A</italic></xref> by extending the analysis to equivalent campaigns in 2019. Expected infections under these policies are plotted in red, and we find that a campaign delayed from November 2018 to May 2019 results in over 600,000 more measles infections on average over the 2018–2021 period.</p>
              <p><xref ref-type="fig" rid="fig03">Fig. 3<italic>B</italic></xref> plots extrapolated model traces for SIAs before (in April, blue) and after (in November, green) the 2018 low-transmission season for more detailed comparison. While the April SIA mitigates infections in 2018, this comes at the expense of a large outbreak in 2020. On the other hand, the November SIA decreases the severity of the predicted 2020 outbreak at the expense of infections in 2018. This tradeoff indicates that transmission seasonality’s contribution to the optimal SIA timing acts in concert with the expected severity of upcoming outbreaks, an expectation which depends directly on measles’ recent history in a population. For Pakistan as a whole, 2017 was a relatively severe measles year, indicating that natural infection has decreased the susceptible population. Consistent with this intuition, model extrapolation predicts that 2020’s outbreak will be larger on average than 2018’s, and the November SIA is preferable as a result.</p>
              <p>The interplay between seasonality and recent history is highlighted if we apply the model to Pakistan’s provinces individually. To do this, the model is fitted to province-level data assuming the national-level transmission seasonality of <xref ref-type="fig" rid="fig01">Fig. 1</xref> with a contact rate scaled by the fraction of Pakistan’s population within the province. The assumption that measles transmission behaves qualitatively similarly across the country is necessary since individual provinces report too few laboratory-confirmed cases to reliably infer province-level transmission parameters. Province-level models are tested by the methods of <xref ref-type="fig" rid="fig02">Fig. 2</xref> in <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 4</ext-link>. They show comparable predictive performance to the national-level model, indicating that the seasonality assumptions are valid.</p>
              <p>Subnationally, Pakistan’s recent measles history has significant heterogeneity. For example, in Pakistan’s two most populated provinces, Punjab and Sindh, laboratory-confirmed measles cases per 100,000 in 2017 were at 0.9 and 6.8, respectively. While this is due in part to RI coverage differences between Punjab and Sindh (<xref rid="r6" ref-type="bibr">6</xref>), this also indicates that 2017 was an outbreak year in Sindh but not in Punjab. This heterogeneity is mirrored in province-level optimal SIA timing: Comparing April and November SIAs where data are available, we see in <xref ref-type="fig" rid="fig03">Fig. 3<italic>C</italic></xref> that in provinces with high 2017 case counts the November campaign is more effective (purple) while in Punjab the April SIA performs better (red). Thus, in line with intuition from the national level, optimizing SIA timing requires a balance between contributions due to seasonality and incidence history. The modeling approach presented here offers a robust means to solve this optimization problem in high-burden contexts.</p>
            </sec>
            <sec sec-type="discussion" id="s3">
              <title>Discussion</title>
              <p content-type="flushleft">Measles vaccination campaign optimization is a complex general problem. Here, we have studied data from Pakistan to demonstrate that SIA timing is a critical factor and that two SIAs with equivalent efficacy and cost may have significantly different impacts solely as a result of their start date. With that in mind, transmission seasonality and recent measles burden, the drivers of optimal campaign timing, should be considered alongside operational constraints in future SIA planning.</p>
              <p>From a methodological perspective, the TSIR model used in this work is a robust tool for evaluating competing SIA polices. While disease models with mass vaccination have been studied in the past (<xref rid="r27" ref-type="bibr">27</xref><xref rid="r28" ref-type="bibr"/>–<xref rid="r29" ref-type="bibr">29</xref>), generalization of a least-squares–based model calibration method (<xref rid="r5" ref-type="bibr">5</xref>) to the high-burden context offers a simple, data-driven SIA optimization approach. Model extensions such as age structure (<xref rid="r30" ref-type="bibr">30</xref>), subnational spatial correlation (<xref rid="r10" ref-type="bibr">10</xref>), and disease importation (<xref rid="r7" ref-type="bibr">7</xref>) are active areas of research. These studies, in conjunction with the method presented here, may contribute to other aspects of SIA optimization, an important problem for measles eradication with widespread global health implications.</p>
            </sec>
            <sec sec-type="methods" id="s4">
              <title>Methods</title>
              <sec id="s5">
                <title>Pakistani Demographic and Surveillance Data.</title>
                <p>Population estimates for 2010 and 2015 and live-birth estimates for 2010, 2012, 2015, and 2020 were obtained from WorldPop (<xref rid="r18" ref-type="bibr">18</xref><xref rid="r19" ref-type="bibr"/>–<xref rid="r20" ref-type="bibr">20</xref>). These were aggregated to the district level and linearly interpolated over time. Rates for the first dose of measles vaccine were estimated using the 2012–2013 DHS (<xref rid="r6" ref-type="bibr">6</xref>) and treated as constant over the 2012–2017 model period, while second-dose rates were estimated using caregiver-reported dose histories associated with laboratory-rejected cases.</p>
                <p>Laboratory-confirmed and -rejected cases were obtained from Pakistan’s WHO-affiliated laboratory. The rejected cases and corresponding self-reported dose histories were used to estimate rates of second-dose measles vaccine coverage in all provinces. Combining these estimates of demographic quantities gives<disp-formula id="uneq1"><mml:math id="me4"><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced open="[" close="]"><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mn>0.9</mml:mn><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>−</mml:mo><mml:mn>0.99</mml:mn><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math></disp-formula>where <inline-formula><mml:math id="i57"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="i58"><mml:msub><mml:mrow><mml:mi>V</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> are first- and second-dose measles vaccine coverage over time, and <inline-formula><mml:math id="i59"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is the estimated live births. The above model assumes the first vaccine dose has a <inline-formula><mml:math id="i60"><mml:mn>90</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> seroconversion rate and the second dose has a <inline-formula><mml:math id="i61"><mml:mn>99</mml:mn><mml:mi>%</mml:mi></mml:math></inline-formula> seroconversion rate (<xref rid="r16" ref-type="bibr">16</xref>). For more details, see <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 1</ext-link>.</p>
              </sec>
              <sec id="s6">
                <title>Fitting and Testing the Model.</title>
                <p>Model fitting to an observed <inline-formula><mml:math id="i62"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> series proceeds in two steps, accounting for uncertainty due to underreporting and transmission individually. In the first step, <xref ref-type="disp-formula" rid="eq1">Eq. <bold>1</bold></xref> is used to construct a weighted least-squares regression of <inline-formula><mml:math id="i63"><mml:msub><mml:mrow><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> against <inline-formula><mml:math id="i64"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> which yields, for a given <inline-formula><mml:math id="i65"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, estimates of <inline-formula><mml:math id="i66"><mml:mi>p</mml:mi></mml:math></inline-formula> and the relative fluctuations in the susceptible population. Further assuming that susceptible fluctuations are small and <inline-formula><mml:math id="i67"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mtext>mod</mml:mtext><mml:mn>24</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, i.e., that seasonality varies only within a year, <xref ref-type="disp-formula" rid="eq2">Eq. <bold>2</bold></xref> defines a generalized linear autoregression of <inline-formula><mml:math id="i68"><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>. Solving this regression problem yields estimates of <inline-formula><mml:math id="i69"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and the remaining parameters including the variance due to transmission uncertainty.</p>
                <p>As mentioned in the main text, we assume <inline-formula><mml:math id="i70"><mml:msub><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>, where <inline-formula><mml:math id="i71"><mml:msub><mml:mrow><mml:mi>P</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is a known measure of target SIA population (<xref rid="r17" ref-type="bibr">17</xref>) and <inline-formula><mml:math id="i72"><mml:mi>μ</mml:mi></mml:math></inline-formula> is an efficacy parameter common to all SIAs from 2012 to 2017. Since the regression approach above can be carried out given a hypothetical <inline-formula><mml:math id="i73"><mml:mi>μ</mml:mi></mml:math></inline-formula>, we take an approach similar to the profile-likelihood optimization used by others (<xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r15" ref-type="bibr">15</xref>). In other words, a range of <inline-formula><mml:math id="i74"><mml:mi>μ</mml:mi></mml:math></inline-formula>s are tested by repeated model fitting and subsequent goodness-of-fit optimization. For mathematical details of the full model calibration procedure and related sensitivity testing see <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new"><italic>SI Appendix</italic>, section 2</ext-link>.</p>
              </sec>
              <sec id="s7">
                <title>Code and Data Availability.</title>
                <p>All analysis was done in Python 3.6.2, and the associated code can be found in the GitHub repository, <ext-link ext-link-type="uri" xlink:href="https://github.com/NThakkar-IDM/campaign_timing" xlink:show="new">https://github.com/NThakkar-IDM/campaign_timing</ext-link> (<xref rid="r31" ref-type="bibr">31</xref>). All data came from open-source providers noted in the references with the exception of the laboratory reports which can be obtained only with permission from the World Health Organization Country Office in Pakistan. To obtain permission, contact the corresponding author (N.T.) or submit a request to the WHO directly (details can be found in the WHO data policy, <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publishing/datapolicy/en/" xlink:show="new">https://www.who.int/publishing/datapolicy/en/</ext-link>).</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material content-type="local-data">
                <label>Supplementary File</label>
                <media xlink:href="pnas.1818433116.sapp.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank Pakistan’s Expanded Program on Immunization for providing the laboratory-reported data, Kurt Frey for useful conversations and significant help with compiling Pakistan’s past SIA calendar, Hil Lyons for assistance with computing birth rates from the DHS, and Caitlin Cornell for useful edits to the manuscript.</p>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement">
                <p>The authors declare no conflict of interest.</p>
              </fn>
              <fn fn-type="other">
                <p>This article is a PNAS Direct Submission.</p>
              </fn>
              <fn fn-type="other">
                <p>Data deposition: The code used in this paper has been deposited in the GitHub repository, <ext-link ext-link-type="uri" xlink:href="https://github.com/NThakkar-IDM/campaign_timing" xlink:show="new">https://github.com/NThakkar-IDM/campaign_timing</ext-link>.</p>
              </fn>
              <fn fn-type="supplementary-material">
                <p>This article contains supporting information online at <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental" xlink:show="new">www.pnas.org/lookup/suppl/doi:10.1073/pnas.1818433116/-/DCSupplemental</ext-link>.</p>
              </fn>
            </fn-group>
            <ref-list>
              <ref id="r1">
                <label>1</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group> (<year>2018</year>) <article-title>Measles fact sheet</article-title>. <comment>Available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs286/en/" xlink:show="new">http://www.who.int/mediacentre/factsheets/fs286/en/</ext-link>. Accessed June 15, 2018</comment>.</mixed-citation>
              </ref>
              <ref id="r2">
                <label>2</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group> (<year>2017</year>) <article-title>Summary of the WHO position on measles vaccine</article-title>. <comment>Available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/immunization/policy/position_papers/measles/en/" xlink:show="new">http://www.who.int/immunization/policy/position_papers/measles/en/</ext-link>. Accessed June 15, 2018</comment>.</mixed-citation>
              </ref>
              <ref id="r3">
                <label>3</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group> (<year>2016</year>) <article-title>Planning and implementing high-quality supplementary immunization activities for injectable vaccines</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.who.int/immunization/diseases/measles/en/" xlink:show="new">http://www.who.int/immunization/diseases/measles/en/</ext-link>. Accessed June 15, 2018</comment>.</mixed-citation>
              </ref>
              <ref id="r4">
                <label>4</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group> (<year>2017</year>) <article-title>Measles cumulative report for 2017</article-title>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/vpi/publications/measles-monthly-bulletin.html" xlink:show="new">http://www.emro.who.int/vpi/publications/measles-monthly-bulletin.html</ext-link>. Accessed June 15</comment>, <year>2018</year>.</mixed-citation>
              </ref>
              <ref id="r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finkenstädt</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name></person-group> (<year>2000</year>) <article-title>Time series modelling of childhood diseases: A dynamical systems approach</article-title>. <source>J R Stat Soc Ser C Appl Stat</source>
<volume>49</volume>:<fpage>187</fpage>–<lpage>205</lpage>.</mixed-citation>
              </ref>
              <ref id="r6">
                <label>6</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><collab>National Institute of Population Studies - NIPS/Pakistan and ICF International</collab></person-group> (<year>2013</year>) <article-title>Pakistan Demographic and Health Survey 2012-13</article-title>. <comment>Available at <ext-link ext-link-type="uri" xlink:href="https://dhsprogram.com/publications/publication-FR290-DHS-Final-Reports.cfm" xlink:show="new">https://dhsprogram.com/publications/publication-FR290-DHS-Final-Reports.cfm</ext-link>. Accessed October 26, 2017</comment>.</mixed-citation>
              </ref>
              <ref id="r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Bjørnstad</surname><given-names>ON</given-names></name>, <name name-style="western"><surname>Kappey</surname><given-names>J</given-names></name></person-group> (<year>2001</year>) <article-title>Travelling waves and spatial hierarchies in measles epidemics</article-title>. <source>Nature</source>
<volume>414</volume>:<fpage>716</fpage>–<lpage>723</lpage>.<pub-id pub-id-type="pmid">11742391</pub-id></mixed-citation>
              </ref>
              <ref id="r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bjørnstad</surname><given-names>ON</given-names></name>, <name name-style="western"><surname>Finkenstädt</surname><given-names>BF</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name></person-group> (<year>2002</year>) <article-title>Dynamics of measles epidemics: Estimating scaling of transmission rates using a time series SIR model</article-title>. <source>Ecol Monogr</source>
<volume>72</volume>:<fpage>169</fpage>–<lpage>184</lpage>.</mixed-citation>
              </ref>
              <ref id="r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Bjørnstad</surname><given-names>ON</given-names></name>, <name name-style="western"><surname>Finkenstädt</surname><given-names>BF</given-names></name></person-group> (<year>2002</year>) <article-title>Dynamics of measles epidemics: Scaling noise, determinism, and predictability with the TSIR model</article-title>. <source>Ecol Monogr</source>
<volume>72</volume>:<fpage>185</fpage>–<lpage>202</lpage>.</mixed-citation>
              </ref>
              <ref id="r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Bjørnstad</surname><given-names>ON</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name></person-group> (<year>2004</year>) <article-title>Measles metapopulation dynamics: A gravity model for epidemiological coupling and dynamics</article-title>. <source>Am Nat</source>
<volume>164</volume>:<fpage>267</fpage>–<lpage>281</lpage><pub-id pub-id-type="pmid">15278849</pub-id></mixed-citation>
              </ref>
              <ref id="r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrari</surname><given-names>MJ</given-names></name>, <etal/></person-group> (<year>2008</year>) <article-title>The dynamics of measles in sub-Saharan Africa</article-title>. <source>Nature</source>
<volume>451</volume>:<fpage>679</fpage>–<lpage>684</lpage>.<pub-id pub-id-type="pmid">18256664</pub-id></mixed-citation>
              </ref>
              <ref id="r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalziel</surname><given-names>BD</given-names></name>, <etal/></person-group> (<year>2016</year>) <article-title>Persistent chaos of measles epidemics in the prevaccination United States caused by a small change in seasonal transmission patterns</article-title>. <source>PLoS Comput Biol</source>
<volume>12</volume>:<fpage>e1004655</fpage>.<pub-id pub-id-type="pmid">26845437</pub-id></mixed-citation>
              </ref>
              <ref id="r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morton</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Finkenstädt</surname><given-names>BF</given-names></name></person-group> (<year>2005</year>) <article-title>Discrete time modelling of disease incidence time series by using Markov chain Monte Carlo methods</article-title>. <source>J R Stat Soc Ser C Appl Stat</source>
<volume>54</volume>:<fpage>575</fpage>–<lpage>594</lpage>.</mixed-citation>
              </ref>
              <ref id="r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramsay</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Hooker</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>J</given-names></name></person-group> (<year>2007</year>) <article-title>Parameter estimation for differential equations: A generalized smoothing approach</article-title>. <source>J R Stat Soc Ser B Stat Methodol</source>
<volume>69</volume>:<fpage>741</fpage>–<lpage>796</lpage>.</mixed-citation>
              </ref>
              <ref id="r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ionides</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Atchadé</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Stoev</surname><given-names>S</given-names></name>, <name name-style="western"><surname>King</surname><given-names>AA</given-names></name></person-group> (<year>2015</year>) <article-title>Inference for dynamic and latent variable models via iterated, perturbed Bayes maps</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>112</volume>:<fpage>719</fpage>–<lpage>724</lpage>.<pub-id pub-id-type="pmid">25568084</pub-id></mixed-citation>
              </ref>
              <ref id="r16">
                <label>16</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Plotkin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Orenstein</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Offit</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>KM</given-names></name></person-group> (<year>2017</year>) <source>Plotkin’s Vaccines</source> (<publisher-name>Elsevier</publisher-name>, <publisher-loc>Philadelphia</publisher-loc>), <edition>7th Ed</edition>.</mixed-citation>
              </ref>
              <ref id="r17">
                <label>17</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group> (<year>2018</year>) <article-title>Summary of measles-rubella supplementary immunization activites, 2000-2018</article-title>. <comment>Available at <ext-link ext-link-type="uri" xlink:href="http://www.who.int/immunization/monitoring_surveillance/data/en/" xlink:show="new">http://www.who.int/immunization/monitoring_surveillance/data/en/</ext-link>. Accessed October 26, 2017</comment>.</mixed-citation>
              </ref>
              <ref id="r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name></person-group> (<year>2017</year>) <article-title>WorldPop, open data for spatial demography</article-title>. <source>Sci Data</source>
<volume>4</volume>:<fpage>170004</fpage>.<pub-id pub-id-type="pmid">28140397</pub-id></mixed-citation>
              </ref>
              <ref id="r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name>, <etal/></person-group> (<year>2014</year>) <article-title>Mapping for maternal and newborn health: The distributions of women of childbearing age, pregnancies and births</article-title>. <source>Int J Health Geographics</source>
<volume>13</volume>:<fpage>2</fpage>.</mixed-citation>
              </ref>
              <ref id="r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaughan</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Linard</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name></person-group> (<year>2013</year>) <article-title>High resolution population distribution maps for Southeast Asia in 2010 and 2015</article-title>. <source>PLoS One</source>
<volume>8</volume>:<fpage>e55882</fpage>.<pub-id pub-id-type="pmid">23418469</pub-id></mixed-citation>
              </ref>
              <ref id="r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simons</surname><given-names>E</given-names></name>, <etal/></person-group> (<year>2012</year>) <article-title>Assessment of the 2010 global measles mortality reduction goal: Results from a model of surveillance data</article-title>. <source>Lancet</source>
<volume>379</volume>:<fpage>2173</fpage>–<lpage>2178</lpage>.<pub-id pub-id-type="pmid">22534001</pub-id></mixed-citation>
              </ref>
              <ref id="r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altizer</surname><given-names>S</given-names></name>, <etal/></person-group> (<year>2006</year>) <article-title>Seasonality and the dynamics of infectious diseases</article-title>. <source>Ecol Lett</source>
<volume>9</volume>:<fpage>467</fpage>–<lpage>484</lpage>.<pub-id pub-id-type="pmid">16623732</pub-id></mixed-citation>
              </ref>
              <ref id="r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharti</surname><given-names>N</given-names></name>, <etal/></person-group> (<year>2011</year>) <article-title>Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery</article-title>. <source>Science</source>
<volume>334</volume>:<fpage>1424</fpage>–<lpage>1427</lpage>.<pub-id pub-id-type="pmid">22158822</pub-id></mixed-citation>
              </ref>
              <ref id="r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharti</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Djibo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tatem</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Grenfell</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>MJ</given-names></name></person-group> (<year>2016</year>) <article-title>Measuring populations to improve vaccination coverage</article-title>. <source>Sci Rep</source>
<volume>6</volume>:<fpage>34541</fpage>.</mixed-citation>
              </ref>
              <ref id="r25">
                <label>25</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><collab>National Oceanic and Atmospheric Administration</collab></person-group> (<year>2018</year>) <article-title>Version 1 VIIRS day/night band nighttime lights</article-title>. <comment>Available at <ext-link ext-link-type="uri" xlink:href="https://www.ngdc.noaa.gov/eog/viirs/" xlink:show="new">https://www.ngdc.noaa.gov/eog/viirs/</ext-link>. Accessed February 4, 2019</comment>.</mixed-citation>
              </ref>
              <ref id="r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yorke</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Nathanson</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Pianigiani</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>J</given-names></name></person-group> (<year>1979</year>) <article-title>Seasonality and the requirements for perpetuation and eradication of viruses in populations</article-title>. <source>Am J Epidemiol</source>
<volume>109</volume>:<fpage>103</fpage>–<lpage>123</lpage>.<pub-id pub-id-type="pmid">218446</pub-id></mixed-citation>
              </ref>
              <ref id="r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>d’Onofrio</surname><given-names>A</given-names></name></person-group> (<year>2002</year>) <article-title>Pulse vaccination strategy in the SIR epidemic model: Global asymptotic stable eradication in presence of vaccine failures</article-title>. <source>Math Comput Model</source>
<volume>36</volume>:<fpage>473</fpage>–<lpage>489</lpage>.</mixed-citation>
              </ref>
              <ref id="r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nieto</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Torres</surname><given-names>A</given-names></name></person-group> (<year>2006</year>) <article-title>Analysis of a delayed epidemic model with pulse vaccination and saturation incidence</article-title>. <source>Vaccine</source>
<volume>24</volume>:<fpage>6037</fpage>–<lpage>6045</lpage>.<pub-id pub-id-type="pmid">16806597</pub-id></mixed-citation>
              </ref>
              <ref id="r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Briat</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Verriest</surname><given-names>EI</given-names></name></person-group> (<year>2009</year>) <article-title>A new delay-SIR model for pulse vaccination</article-title>. <source>Biomed Signal Process Control</source>
<volume>4</volume>:<fpage>272</fpage>–<lpage>277</lpage>.</mixed-citation>
              </ref>
              <ref id="r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuniya</surname><given-names>T</given-names></name></person-group> (<year>2011</year>) <article-title>Global stability analysis with a discretization approach for an age-structured multigroup SIR epidemic model</article-title>. <source>Nonlinear Anal Real World Appl</source>
<volume>12</volume>:<fpage>2640</fpage>–<lpage>2655</lpage>.</mixed-citation>
              </ref>
              <ref id="r31">
                <label>31</label>
                <mixed-citation publication-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Thakkar</surname><given-names>N</given-names></name></person-group> (<year>2019</year>) <article-title>Data from “A time series model for forecasting measles vaccination campaign impact.”</article-title>
<comment>GitHub. Available at <ext-link ext-link-type="uri" xlink:href="https://github.com/NThakkar-IDM/campaign_timing" xlink:show="new">https://github.com/NThakkar-IDM/campaign_timing</ext-link>. Deposited February 11, 2019</comment>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
